NCT03544411 is a Phase 1 clinical trial of olive oil in Diabetes Mellitus, Type 2, sponsored by Indonesia University.

Who is sponsoring NCT03544411?

NCT03544411 is sponsored by Indonesia University.

What drugs are being tested in NCT03544411?

Interventions in NCT03544411: olive oil, bran oil.

What condition does NCT03544411 study?

NCT03544411 studies Diabetes Mellitus, Type 2, Oxidative Stress, Glucose, High Blood, Lipid Disorder.

Is NCT03544411 still recruiting?

NCT03544411 is currently completed. Last updated 16 October 2018.

Last reviewed 2018-10-16 · How we verify

NCT03544411

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Olive Oil and Bran Oil on Antioxidant Levels, Glycemic Control, and Lipid Profile in Patient Type 2 DM

Completed Phase 1 Last updated 16 October 2018

What this trial tests

Phase 1 trial testing olive oil in Diabetes Mellitus, Type 2 in 10 participants. Completed in 5 October 2018.

Timeline

2 July 2018

Primary endpoint
20 September 2018

5 October 2018

Quick facts

Lead sponsor	Indonesia University
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	treatment
Enrollment	10
Start date	2 July 2018
Primary completion	20 September 2018
Estimated completion	5 October 2018
Sites	1 location across Indonesia

Drugs / interventions tested

olive oil — full drug profile →
bran oil — full drug profile →

Conditions studied

Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Oxidative Stress — all drugs for Oxidative Stress →
Glucose, High Blood — all drugs for Glucose, High Blood →
Lipid Disorder — all drugs for Lipid Disorder →

Sponsor

Indonesia University

Who can join

Adults 30 to 60, any sex, with Diabetes Mellitus, Type 2 or Oxidative Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study determines the effect of olive oil and bran oil on antioxidant levels, and glycemic control in patients with type 2 diabetes mellitus (DM) Intervention: Patient type 2 DM will receive olive oil and bran oil with cross over study

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of olive oil

Trials testing the same drug.

NCT06254118 — Treatment of Periodontitis in Menopausal Patients · Phase 4 · completed
NCT03399331 — Honey or Olive Oil for Treating Oral Mucositis in Children and Adults With Leukemia Receiving Intensive Chemotherapy · Phase 1 · completed

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting

Other Indonesia University trials

Trials by the same sponsor.

NCT07137130 — Secretome TGF Beta 3 · NA · not yet recruiting
NCT07420335 — Preoperative Shoulder Exercises and Postoperative Inflammation, Pain, and Function After Modified Radical Mastectomy · NA · not yet recruiting
NCT07278284 — The Effectiveness of Press Needle Acupuncture on Preoperative Anxiety in Tympanoplasty and Mastoidectomy · NA · recruiting
NCT07337187 — Effect of Thread-Embedding Acupuncture at EX-B2 on Pain and Quality of Life in Chronic Low Back Pain · NA · not yet recruiting
NCT07242001 — Laser Acupuncture for Otitis Media With Effusion in Children · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03544411 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Indonesia University
Last refreshed: 16 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03544411.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing